| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $335,949,131 ) (Continued on the next page) |
| | 2025 | 2025 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01HL176770 | Regulation of disease progression by ER stress | 000 | 1 | NIH | 8/18/2025 | $663,730 |
| | 2025 | 2025 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | UG3AG101701 | Exploiting accelerated aging associated with Low Earth Orbit (LEO) environment to gain insights into pathogenesis and treatment of progressive neurological disorders | 000 | 1 | NIH | 8/18/2025 | $2,815,841 |
| | 2025 | 2025 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | F31AG092133 | Interneuron circadian rhythms and tau-dependent network excitability in Alzheimer's disease pathogenesis | 001 | 1 | NIH | 8/20/2025 | $0 |
| | 2025 | 2025 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | F30AG092080 | TREM2 activation by vitamin D3 in the pathogenesis of Alzheimer's disease | 000 | 1 | NIH | 8/13/2025 | $43,420 |
| | 2025 | 2025 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | F31AG092133 | Interneuron circadian rhythms and tau-dependent network excitability in Alzheimer's disease pathogenesis | 000 | 1 | NIH | 8/20/2025 | $40,828 |
| | 2025 | 2025 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01AG082089 | The role of IncRNA Neat1 in Alzheimer's disease and related memory deficits | 001 | 3 | NIH | 6/9/2025 | $52,568 |
| | 2025 | 2025 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01AG082089 | The role of IncRNA Neat1 in Alzheimer's disease and related memory deficits | 000 | 3 | NIH | 3/7/2025 | $591,400 |
| | 2025 | 2025 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | F30MH139313 | The Role of Immune Cells within Maternal Immune Activation-Induced Behavioral Deficits | 000 | 1 | NIH | 8/21/2025 | $43,420 |
| | 2025 | 2025 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R13HL182313 | 19th International Conference on Endothelin: From New Discoveries to New Treatments | 000 | 1 | NIH | 8/15/2025 | $5,000 |
| | 2025 | 2025 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | K01HL175108 | Implementation of streamlined, standardized blood pressure measurement protocols in primary care | 000 | 1 | NIH | 8/15/2025 | $162,703 |
| | 2025 | 2025 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01AG079129 | Influence of thalamic IL-33 signaling in aging-associated exacerbation of cognitive impairment after brain injury via microglial dysfunction and tau pathology | 000 | 2 | NIH | 8/19/2025 | $445,757 |
| | 2025 | 2025 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | F30HL177982 | The Role of CXCL9 and CXCL10 in Adverse Cardiac Remodeling Following Streptococcus pneumoniae Infection | 001 | 1 | NIH | 8/30/2025 | $0 |
| | 2025 | 2025 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | 90IFRE0093 | Participation of People with Disabilities in Research: A Participatory Approach Mixed-Methods Study and Monitoring Dashboard | 00 | 2 | ACL | 9/5/2025 | $199,999 |
| | 2025 | 2025 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | F30HL177982 | The Role of CXCL9 and CXCL10 in Adverse Cardiac Remodeling Following Streptococcus pneumoniae Infection | 000 | 1 | NIH | 8/30/2025 | $41,233 |
| | 2025 | 2025 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | RF1MH130539 | Neural-Derived Plasma Exosomal MicroRNAs As Promising Novel Biomarkers for Suicidality and Treatment Outcome in Adolescents | 000 | 4 | NIH | 9/2/2025 | $1,479,918 |
| | 2025 | 2025 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | K24HL180320 | Mentored Patient-Oriented Research in Natriuretic Peptide System Based Precision Cardiometabolic Health | 000 | 1 | NIH | 8/27/2025 | $132,623 |
| | 2025 | 2025 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R00AA030031 | The Effect of Light Intervention on Recovery in Individuals with Opioid Use Disorder (OUD) | 000 | 2 | NIH | 9/16/2025 | $248,990 |
| | 2025 | 2025 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | K23HL175238 | Venous Thromboembolism: Enhancing Representation in Clinical Trials and Investigation of Sociodemographic and Clinical Factors Associated with Secondary Anticoagulation Use and Outcomes in Children | 000 | 1 | NIH | 9/17/2025 | $186,153 |
| | 2025 | 2025 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01DK144096 | Histone H3 O-GlcNAcylation in Endothelial Cells Promotes Diabetic Vascular Complications | 000 | 1 | NIH | 9/5/2025 | $2,381,683 |
| | 2025 | 2025 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | RF1AG094716 | Amyloid-mediated cognitive dysfunction in bacterial pneumonia after TBI | 000 | 1 | NIH | 9/8/2025 | $2,663,195 |
| | 2025 | 2025 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R21HL182473 | Role of Integrase Strand Transfer Inhibitors on Hypertension in People with HIV | 000 | 1 | NIH | 9/4/2025 | $223,438 |
| | 2025 | 2025 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01MH136851 | PrOTECT AL: PrEP Optimization Through Enhanced Continuum Tracking | 000 | 1 | NIH | 9/20/2025 | $790,198 |
| | 2025 | 2025 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | M0255250 | Behavioral Health Workforce Education and Training Program for Paraprofessionals | 00 | 1 | HRSA | 9/4/2025 | $349,999 |
| | 2025 | 2025 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R00AI173401 | Non-tuberculous mycobacterium and B cells in the stimulation of ectopic germinal centers and immunological control of pulmonary tuberculosis | 000 | 3 | NIH | 9/15/2025 | $249,000 |
| | 2025 | 2025 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | P30AI027767 | UAB Center for AIDS Research (CFAR) | 001 | 35 | NIH | 2/25/2025 | $98,600 |
| | 2025 | 2025 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | P30AI027767 | UAB Center for AIDS Research (CFAR) | 001 | 35 | NIH | 2/25/2025 | $34,500 |
| | 2025 | 2025 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | P30AI027767 | UAB Center for AIDS Research (CFAR) | 001 | 35 | NIH | 2/25/2025 | $34,500 |
| | 2025 | 2025 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | P30AI027767 | UAB Center for AIDS Research (CFAR) | 001 | 35 | NIH | 2/25/2025 | $119,350 |
| | 2025 | 2025 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01MD019235 | Improving COVID-19 Vaccine Uptake Among Racial and Ethnic Minority Groupswith Rheumatic Diseases | 004 | 3 | NIH | 7/10/2025 | $489,732 |
| | 2025 | 2025 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | P30AI027767 | UAB Center for AIDS Research (CFAR) | 001 | 35 | NIH | 2/25/2025 | $1,006,240 |
| | 2025 | 2025 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | P30AI027767 | UAB Center for AIDS Research (CFAR) | 001 | 35 | NIH | 2/25/2025 | $57,100 |
| | 2025 | 2025 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01MD019235 | Improving COVID-19 Vaccine Uptake Among Racial and Ethnic Minority Groupswith Rheumatic Diseases | 004 | 3 | NIH | 7/10/2025 | $125,000 |
| | 2025 | 2025 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01AR085886 | Gout Epidemiology in Chronic Kidney Disease: Transition to End-stage Kidney Disease and Impact of Renal Transplant | 000 | 1 | NIH | 7/10/2025 | $240,715 |
| | 2025 | 2025 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | P30AI027767 | UAB Center for AIDS Research (CFAR) | 001 | 35 | NIH | 2/25/2025 | $37,800 |
| | 2025 | 2025 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01CA276683 | Development of Potent and non-toxic rexinoids to prevent non-melanoma skin cancer | 001 | 3 | NIH | 5/22/2025 | $61,011 |
| | 2025 | 2025 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | P30AI027767 | UAB Center for AIDS Research (CFAR) | 001 | 35 | NIH | 2/25/2025 | $34,500 |
| | 2025 | 2025 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | F30DE033624 | The Role of Ubiquitin Conjugating Enzyme (Ubc9) in Endochondral Ossification | 000 | 2 | NIH | 3/17/2025 | $57,774 |
| | 2025 | 2025 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | TL1DK139566 | Deep South KUH Premier Research - Interdisciplinary Mentored Education (PRIME) Training Core | 002 | 3 | NIH | 8/18/2025 | $148,523 |
| | 2025 | 2025 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | TL1DK139566 | Deep South KUH Premier Research - Interdisciplinary Mentored Education (PRIME) Training Core | 001 | 3 | NIH | 6/12/2025 | $747,592 |
| | 2025 | 2025 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01NS141959 | Epigenetic entrainment of striatal engram-like neurons across the time course of LID development | 000 | 1 | NIH | 6/18/2025 | $350,036 |
| | 2025 | 2025 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01CA269568 | Overcoming obesity-associated immunotherapy resistance in renal cancer | 001 | 3 | NIH | 5/22/2025 | $52,196 |
| | 2025 | 2025 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01CA269568 | Overcoming obesity-associated immunotherapy resistance in renal cancer | 000 | 3 | NIH | 3/3/2025 | $469,773 |
| | 2025 | 2025 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R35GM159958 | Probing the Effects of Pathological Conditions on AKT | 000 | 1 | NIH | 8/12/2025 | $2,011,691 |
| | 2025 | 2025 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01ES037611 | Studying The Mechanisms of Delayed Lung Injury Post-Arsenical Exposures | 000 | 1 | NIH | 8/28/2025 | $1,341,000 |
| | 2025 | 2025 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R35GM159908 | Contemporary Human Models of Postoperative Pain: A Biopsychosocial Investigation in General Surgery | 000 | 1 | NIH | 8/25/2025 | $371,871 |
| | 2025 | 2025 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01NS138515 | Targeting Radiation-Induced Glioblastoma Invasion | 000 | 1 | NIH | 8/4/2025 | $339,436 |
| | 2025 | 2025 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01HL178662 | Unveiling the Atheroprone Role of Novel Mechanosensitive Histone Modification | 000 | 1 | NIH | 8/1/2025 | $535,556 |
| | 2025 | 2025 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01CA279143 | Utilization of Immuno-PET to detect response and guide novel oHSV-based therapy for glioma | 001 | 3 | NIH | 5/22/2025 | $57,144 |
| | 2025 | 2025 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01CA279143 | Utilization of Immuno-PET to detect response and guide novel oHSV-based therapy for glioma | 000 | 3 | NIH | 3/20/2025 | $514,300 |
|
